Citigroup’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $600 | Buy |
251
+61
| +32% | +$146 | ﹤0.01% | 4684 |
|
|
2025
Q1 | $818 | Buy |
190
+88
| +86% | +$379 | ﹤0.01% | 4586 |
|
|
2024
Q4 | $877 | Sell |
102
-253
| -71% | -$2.18K | ﹤0.01% | 4734 |
|
|
2024
Q3 | $6.04K | Sell |
355
-512
| -59% | -$8.71K | ﹤0.01% | 4536 |
|
|
2024
Q2 | $13.1K | Buy |
867
+263
| +44% | +$3.97K | ﹤0.01% | 4346 |
|
|
2024
Q1 | $10K | Buy |
604
+324
| +116% | +$5.38K | ﹤0.01% | 4439 |
|
|
2023
Q4 | $4.48K | Buy |
280
+227
| +428% | +$3.63K | ﹤0.01% | 4572 |
|
|
2023
Q3 | $4.04K | Sell |
53
-235
| -82% | -$17.9K | ﹤0.01% | 4031 |
|
|
2023
Q2 | $18.9K | Buy |
+288
| New | +$18.9K | ﹤0.01% | 4286 |
|
|
2022
Q4 | – | Sell |
-750
| Closed | -$25K | – | 5076 |
|
|
2022
Q3 | $25K | Sell |
750
-38
| -5% | -$1.27K | ﹤0.01% | 3948 |
|
|
2022
Q2 | $21K | Buy |
788
+712
| +937% | +$19K | ﹤0.01% | 4289 |
|
|
2022
Q1 | $2K | Sell |
76
-187
| -71% | -$4.92K | ﹤0.01% | 5273 |
|
|
2021
Q4 | $22K | Buy |
263
+147
| +127% | +$12.3K | ﹤0.01% | 4592 |
|
|
2021
Q3 | $9K | Buy |
116
+86
| +287% | +$6.67K | ﹤0.01% | 4743 |
|
|
2021
Q2 | $3K | Buy |
+30
| New | +$3K | ﹤0.01% | 5257 |
|